We are live on
!
Find out more
DBG
De Burlo Group Portfolio holdings
AUM
$441M
1-Year Est. Return
21.21%
This Fund
S&P 500
This Quarter
Est. Return
+11.49%
1 Year Est. Return
+21.21%
3 Year Est. Return
+98.05%
5 Year Est. Return
+220.33%
10 Year Est. Return
+1,846.98%
AUM
$601M
AUM Growth
+$89M
(+17%)
Cap. Flow
+$40.9M
Cap. Flow
% of AUM
6.81%
Top 10 Holdings %
Top 10 Hldgs %
41.06%
Holding
94
New
4
Increased
28
Reduced
31
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$20.4M |
| 2 |
Eli Lilly
LLY
|
+$18.2M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$13.4M |
| 4 |
Monster Beverage
MNST
|
+$10.6M |
| 5 |
Dynatrace
DT
|
+$10.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$16.9M |
| 2 |
United Rentals
URI
|
+$10.7M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$8.54M |
| 4 |
SPLK
Splunk Inc
SPLK
|
+$8.32M |
| 5 |
Tesla
TSLA
|
+$7.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.01% |
| 2 | Healthcare | 19.55% |
| 3 | Consumer Discretionary | 10.9% |
| 4 | Industrials | 10.05% |
| 5 | Financials | 7.4% |
Similar funds
ECA
DWML
BOA
PLU
CPW
AWM
CAAM
SCP
De Burlo Group's Q2 2023 Portfolio in Review
As of Q2 2023, De Burlo Group held 94 positions worth $601M, up 17% from $512M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
De Burlo Group deployed $40.9M of net new capital in Q2 2023, opening 4 new positions and adding to 28 existing holdings. Its largest new stake was iShares Russell 2000 ETF: 114,300 shares worth $21.4M.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $7.6M trimmed.
- De Burlo Group's largest Q2 2023 buy was iShares Russell 2000 ETF: 114,300 shares worth $21.4M.
- De Burlo Group added most to Eli Lilly in Q2 2023, an estimated $18.2M increase.
- De Burlo Group's biggest Q2 2023 reduction was Tesla, cutting an estimated $7.6M.
- De Burlo Group fully exited Regeneron Pharmaceuticals in Q2 2023, selling an estimated $16.9M.
- De Burlo Group's ten largest holdings make up 41% of its $601M portfolio in Q2 2023.
- De Burlo Group opened 4 new positions and closed 8 in Q2 2023.
- De Burlo Group's portfolio value rose 17% quarter-over-quarter to $601M.
Based on De Burlo Group's 13F filing for Q2 2023, filed 14 Aug 2023.